Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Chronic Obstructive Pulmonary Disease (COPD) Research, Venous Thromboembolism Diagnosis and Management, and Cardiovascular Issues in Pregnancy.
Burden of pulmonary arterial hypertension in Asia from 1990 to 2021: Findings from Global Burden of Disease Study 2021
Pulmonary arterial hypertension: a long-standing and nonnegligible burden over three decades
Coronary artery stenosis associated with right ventricular dysfunction in acute pulmonary embolism: A case-control study
Treatment algorithm for pulmonary arterial hypertension
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension
Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension
Development and external validation of a nomogram for predicting short-term prognosis in patients with acute pulmonary embolism
Association between coronary artery stenosis and myocardial injury in patients with acute pulmonary embolism: A case-control study
A Novel Nomogram for Predicting All-cause Mortality in Pulmonary Embolism Patients: A Clinical Study Based on the MIMIC-IV and PE Database
The Global Burden of Pulmonary Arterial Hypertension from 1990 to 2021: Systematic Analysis for the Global Burden of Disease Study 2021
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction
Human Plasma IgG <i>N</i> -Glycome Profiles Reveal a Proinflammatory Phenotype in Chronic Thromboembolic Pulmonary Hypertension
2023 Chinese expert consensus on the impact of COVID-19 on the management of cardiovascular diseases
Real‐world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real‐world Evidence Working Group
Human Plasma Immunoglobulin G N-Glycome Profiles Reveal a Pro-Inflammatory Phenotype in Chronic Thromboembolic Pulmonary Hypertension: A Cross-Sectional Study of Two Independent Cohorts
Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day
2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy
Clinical features and survival in Takayasu’s arteritis-associated pulmonary hypertension: a nationwide study
Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart disease
DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension
Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension
MicroRNA‐483 amelioration of experimental pulmonary hypertension
Challenges and Special Aspects of Pulmonary Hypertension in Middle- to Low-Income Regions
Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis
Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing
Antiphospholipid Syndrome in Chronic Thromboembolic Pulmonary Hypertension: A Well-Defined Subgroup of Patients
Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis
Lipocalin-2 Predicts Long-Term Outcome of Normotensive Patients with Acute Pulmonary Embolism
Risk stratification and medical therapy of pulmonary arterial hypertension